Search results
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 6 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit By Reuters
Investing.com· 6 days agoIn a lawsuit filed in the District Court of Thomas County, the state said the New York-based...
Pfizer Inc. (NYSE:PFE) Shares Sold by Trust Co. of Vermont
ETF DAILY NEWS· 6 days agoTrust Co. of Vermont lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing ...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 1 day agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 5 days agoThe state of Kansas has filed a lawsuit against Pfizer alleging the company misled the public about...
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during ...
Pfizer 'can't rule out' layoffs in North Carolina after gene therapy flub - Triangle Business...
The Business Journals· 5 days agoLayoffs could by on the way at Pfizer's massive facility in Sanford after the company's gene therapy...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Kansas City Star via Yahoo News· 6 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 5 days agoPfizer Currently Dominates Market FDA approval of Merck’s new pneumococcal vaccine, Capvaxive, tees...